TABLE 2

Group	n	Dose and route	mg PrC-210 applied	NEp	Cmax (ng-eq/g)	Tmax (h)	Recoverya (excreta)	Recovery (carcass)	Recoveryb (systemic)	Recoveryc (skin)	Recoveryd (total)
1	3	370 mM 100 μCi Dermal	16.28	-	257	4	6.18%	0.52%	6.70%	41.54%	49.4%
2	3	1850 mM 100 μCi Dermal	81.40		1,630	8	13.28%	1.84%	15.12%	47.16%	66.0%
3	3	1850 mM 100 μCi Dermal	81.40		726	48	6.88%	1.53%	8.41%	60.46%	70.0%
4	3	370 mM 100 μCi Dermal	16.28		0.22% of topically administered dose was recoverable in expired air over 48 h

^aRecovery (excreta) = urine + urine wipes + feces.

^bRecovery (systemic) = Recovery (excreta) + Recovery (carcass).

^cRecovery (skin) = skin (dose site) + skin wash.

^dRecovery (total) = Recovery (systemic) + Recovery (skin) + cage wash + cage wipe + enclosure + nonocclusive cover.